News | January 29, 2015

VuComp Further Expands Patent Portfolio

Intellectual property related to computer-aided detection of breast cancer gains strength

Computer-aided detection breast, mammography, women's health, M-Vu CAD

Image courtesy of VuComp

January 29, 2015 — VuComp Inc. announced that two additional patents have been issued to the company, extending its intellectual property related to computer-aided detection of breast cancer.

The patents cover a key cancer detection component of the M-Vu CAD system. Together, they include the ability to find suspicious looking calcification clusters and areas with spiculations, which make the system sensitive to finding areas of interest that are consistent with cancer. VuComp has another seven patents pending related to its breast cancer detection products.

VuComp’s M-Vu CAD system was the first mammography CAD product to meet the FDA standard that recommends comprehensive reader studies to prove the effectiveness of CAD systems.

"The new patents continue to distinguish VuComp as a pioneer in the development of the most advanced CAD system for mammography," said James Pike, president and chief technology officer, VuComp. "Our commitment to advancing our technology and adding to our intellectual property estate delivers tremendous value to our customers, patients and investors."

For more information:

Related Content

Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Sponsored Content | Videos | Breast Imaging | January 11, 2019
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Opto-Acoustic Imaging Helps Differentiate Breast Cancer Molecular Subtypes
News | Ultrasound Women's Health | December 20, 2018
Seno Medical Instruments Inc. (Seno Medical) reported results of a study demonstrating that morphologic and functional...
Densitas Enters Platform Partnership With Blackford
News | Breast Density | December 19, 2018
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
Videos | Artificial Intelligence | December 13, 2018
ITN Editor Dave Fornell and ITN Contributing Editor Greg Freiherr share their insights on the vendors showing...
RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...